Antibodies

SCIE

国际简称：ANTIBODIES 参考译名：抗体

主要研究方向：IMMUNOLOGY 非预警期刊审稿周期：11 Weeks

《抗体》(Antibodies)是一本由MDPI AG出版的以IMMUNOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q3 JCR分区
109 年发文量
3.3 IF影响因子
未开放 是否OA
4 issues/year 出版周期
English 出版语言

Antibodies is an international open access journal focused on the field of antibody science, published by MDPI Press. This journal covers the structure, function, production, application, and related immunological research of antibodies. It aims to promote basic and applied research in antibody science, including the latest developments in antibody engineering, immunotherapy, vaccine development, and more. The content of journals not only includes original research papers, but also systematic reviews and comprehensive analytical articles. The journal adopts a single blind peer review system to ensure that the published research has high academic standards and innovation. In addition, the journal emphasizes a fast publishing process to accelerate the dissemination of scientific research results.

The journal is included in multiple databases, including Scopus, ESCI, PubMed, PMC, EMBASE, and Chemical Abstracts, further demonstrating its recognition and visibility in the academic community. The editorial and review teams of the journal are composed of internationally renowned scientists who work together to maintain the academic quality and international perspective of the issue. It is an important platform for antibody science researchers and related professionals to publish and obtain high-quality research results.

[ 查看全部 ]

投稿咨询加急咨询

Antibodies期刊信息

ISSN：2073-4468
出版语言：English
是否OA：未开放
出版地区：Switzerland
是否预警：否
出版商：MDPI AG
出版周期：4 issues/year
开源占比：0.9895
Gold OA文章占比：100.00%
OA被引用占比：1
出版国人文章占比：0.02
出版撤稿占比：
研究类文章占比：70.64%

Antibodies CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

4.9

0.906

0.922

学科类别	分区	排名	百分位
大类：Medicine 小类：Immunology and Allergy	Q2	110 / 234	53%
大类：Medicine 小类：Drug Discovery	Q2	77 / 161	52%
大类：Medicine 小类：Immunology	Q3	124 / 243	49%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Antibodies中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	IMMUNOLOGY 免疫学	3区

Antibodies JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	ESCI	Q3	99 / 183	46.2
学科：IMMUNOLOGY	ESCI	Q3	135 / 183	26.5

Antibodies历年数据统计

影响因子

中科院分区

Antibodies中国学者发文选摘

1、Development of a Human IgG1 Monoclonal Antibody Targeting Transferrin Receptor 1 for Antitumor Drug Deliver
Author: Ji, Tingting; Zong, Zhaoyun; Gong, Ningyuan; Yan, Minghui; Chen, Shiyu

Journal: ANTIBODIES. 2026; Vol. 15, Issue 2, pp. -. DOI: 10.3390/antib15020034
2、Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validatio
Author: Liu, Yunfeng; Huang, Qiting; Zhang, Dongna; Wang, Yingjun; Zhao, Shuaiying; Wen, Jianchuan; Kong, Yingying; Xu, Jianfeng

Journal: ANTIBODIES. 2026; Vol. 15, Issue 2, pp. -. DOI: 10.3390/antib15020019
3、Antibody Screening and Binding Prediction Analysis Targeting Stx
Author: Wu, Jilei; Liu, Chenghua; Peng, Fenghao; Yu, Zeyuan; Qiao, Chunxia; Yang, Guang; Luo, Heng; Sun, Keyi; Ning, Ziyao; Wang, Jing; Wen, Yan; Yu, Jijun

Journal: ANTIBODIES. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.3390/antib15010011
4、Humanized VHH-hFc Fusion Proteins Targeting the L-HN Fragment of Tetanus Toxin Provided Protection In Viv
Author: Li, Yating; Cheng, Kexuan; Guo, Jiazheng; Jiang, Yujia; Kang, Qinglin; Wang, Rong; Du, Peng; Gao, Chen; Yu, Yunzhou; Yang, Zhixin; Wang, Wei; Lu, Jiansheng

Journal: ANTIBODIES. 2025; Vol. 14, Issue 2, pp. -. DOI: 10.3390/antib14020048